Advertisement

Topics

Companies Related to "Russia Launches Gene editing Research Program" [Most Relevant Company Matches] RSS

04:24 EDT 17th July 2019 | BioPortfolio

Here are the most relevant search results for "Russia Launches Gene editing Research Program" found in our extensive corporate database of over 50,000 company records.

Showing "Russia Launches Gene editing Research Program" Companies 1–25 of 7,900+

Extremely Relevant

Inscripta

Inscripta is a gene editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, single cell engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene editing tools (instruments, reagents, ...


Relevant

Recombinetics

A private company founded in 2008, Recombinetics has emerged as a global leader in proprietary gene repair and gene-editing technology. Breakthrough scientific research – including the development of TALEN technologies – has resulted in global exclusive rights in the biomedical, animal agriculture and livestock vertical markets.

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is bac...


Gene Smart

Gene Smart Wellness is a preventative healthcare company dedicated to pioneering real world approaches that empower individuals to take control of their whole health in order to live abundantly. The company's innovations include its Living Abundantly Community Wellness Program, the Gene Smart Omega-3 Index Home Blood Test and the Gene Smart Anti-Inflammation Diet & Exercise Program. More informati...

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com

Takara Bio USA, Inc.

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life sciences research applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sampl...

English Manager Science Editing

English Manager Science Editing is an Australian business that aims to provide a fast, efficient excellent-quality English language scientific editing service using the Internet. We use experienced freelance scientific editors with diverse backgrounds. Dr. Scott Butler - Managing EditorScott completed his Ph.D. in 1995 in the Department of Theoretical Chemistry at the University of Sydney. Subsequ...

Gene Research Lab. CO. LTD

Medical doctors, doctors of immunology , and doctors of molecular biology are the major participants of Gene Research Lab. Gene Research Lab., was founded at Pei-Tou and started to collaborate with doctors in hospital centers from 1999. This highly competitive team works hard to standardize research quality and to reengineer new ways of Biomedicine production. By the ample experiences in this indu...

LogicBio Therapeutics, Inc.

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for life-threatening diseases. Its GeneRide™ technology enables highly specific genome editing and integration of the therapeutic transgene, utilizing the body's own native proc...

COBO Technologies

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Gene Check Inc

Gene Check, Inc. is a growing biotechnology company located in Fort Collins, Colorado. In addition to a dynamic program of research and development, Gene Check produces and markets reagents and kits for research and offers veterinary genotyping tests for sheep. Gene Check was founded in 1993 by Drs. Robert Wagner and Miroslav Radman. Drs. Wagner and Radman have been colleagues and collaborators si...

AVROBIO, Inc.

AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical-stage company developing disruptive therapies that have the potential to transform patients’ lives with a single dose. The Company is focused on the development of its Phase 1 program in Fabry disease and pre-Phase 1/2 program in Gaucher disease, while actively building a pipeli...

Avellino Labs

Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm...

Genetix Pharmaceuticals Incorporated

The government of France, working with leading research institutions across the country, recently inaugurated and financed a national, multi-disciplinary, multi-million dollar program to identify as exhaustively as possible those genes whose alteration directly causes all the known types of human cancers. Because of its unique expertise in gene transfer technology, GENETIX was chosen as its first ...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

Precision BioSciences Inc.

Precision BioSciences’ mission is to continually provide, improve, and enable the world’s most powerful genome engineering technology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant ce...

Sequitur Incorporated

Sequitur, Inc. was founded in 1996 to develop innovative sequence-based compounds for functional genomics research, diagnostic and therapeutic applications. Sequitur's proprietary antisense technology can be employed to determine gene function and validate small molecule targets by specifically inhibiting gene expression. We also offer a line of products and services relating to gene expression...

Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics...

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AA...

Precision BioSciences, Inc.

Precision's mission is to utilize its engineered endonuclease technology to become the world leader in the field of genomic molecular biology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of custom genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or pla...

Rocket Pharmaceuticals, Ltd.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (A...

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a leader in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics’ pipeline includes three clinical stage g...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology related to gene transfer and therapy and to serve as a professional adviser to the community and to the regulatory bodies in Europe.

Paradigm Genetics Incorporated

Paradigm Genetics is industrializing the process of gene function determination for four major sectors of the global economy: human health, nutrition, crop production, and industrial products. We believe that gene function rather than gene sequence will ultimately create a new paradigm in industrializing functional genomics. This belief is the key to our business, research, and patent strategy. We...


More From BioPortfolio on "Russia Launches Gene editing Research Program"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks